The long term objectives of this grant are to understand the mucosal environment of the healthy female genital tract in terms of its non-immune protective mechanisms against Trichomonas vaginalis and other STDs including HIV infection, and the inflammatory response. Experiments will focus on protective mechanisms provided by secretory leukocyte protease inhibitor (SLPI), a predominant serine protease inhibitor found on the vaginal epithelium and determine the deleterious effects of T. vaginalis proteases (TVPs) on SLPI function. We hypothesize that Trichomonas vaginalis (TV) cysteine proteases cleave secretory leukocyte protease inhibitor (SLPI) and impair its mucosal antimicrobial defense function. We plan to: 1) determine the normal antimicrobial function of SLPI against STD organisms including Trichomonas vaginalis (TV), Neisseria gonorrhoeae (GC), and Chlamydia trachomatis (CT). 2) determine the antimicrobial function of SLPI under different broth growth and metabolic conditions of TV including aerobic and anaerobic growth; different concentrations of free iron, and human transferrin and lactoferrin; and in the presence and absence of cysteine protease inhibitor E-64. 3) isolate and characterize the specific TVP activity which causes the degradation of SLPI. Three TVPs (220, 92 and 68 kDa) will be isolated by ion exchange chromatography of induction supernatants and tested for their individual degradative effects on SLPI by SDS-PAGE and Western blot. 4) Resulting peptide fragments will be sequenced by gas phase microsequencing. The TVP cleavage sites and peptides will be mapped to known sequence data and functional domains. 5) Residual antimicrobic function of peptides will be tested, 6) We will determine SLPI levels in normal and infected secretions from the adolescent female genital tract. Adolescent girls, ages 14-19, will have vaginal fluid samples taken and SLPI levels determined by ELISA assay. These patients will be followed longitudinally lover a year and SLPI levels compared to Lactobacillus crispatus carriage rates, The mechanisms elucidated here will be relevant to our understanding of native vaginal mechanisms of homeostasis and during infection with simple or complicated genital tract disease. These findings may also be relevant to mechanisms of infection of other mucosal STD pathogens, including HIV infection, and other parasitic diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI047785-02
Application #
6340747
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
$84,558
Indirect Cost
Name
Magee-Women's Hospital of Upmc
Department
Type
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Cook, Robert L; Downs, Julie S; Marrazzo, Jeanne et al. (2009) Preferred characteristics of vaginal microbicides in women with bacterial vaginosis. J Womens Health (Larchmt) 18:1163-7
Bunge, Katherine E; Beigi, Richard H; Meyn, Leslie A et al. (2009) The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Transm Dis 36:711-3
Antonio, May A D; Meyn, Leslie A; Murray, Pamela J et al. (2009) Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis 199:1506-13
Beigi, Richard H; Yudin, Mark H; Cosentino, Lisa et al. (2007) Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. J Infect Dis 196:1355-60
Marrazzo, Jeanne M; Wiesenfeld, Harold C; Murray, Pamela J et al. (2006) Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 193:617-24
Marrazzo, Jeanne M; Cook, Robert L; Wiesenfeld, Harold C et al. (2006) Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Womens Health (Larchmt) 15:1053-60
Kwok, Louisa; Stapleton, Ann E; Stamm, Walter E et al. (2006) Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. J Urol 176:2050-4; discussion 2054
Austin, M N; Beigi, R H; Meyn, L A et al. (2005) Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 43:4492-7
Antonio, May A D; Rabe, Lorna K; Hillier, Sharon L (2005) Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 192:394-8
Beigi, Richard H; Austin, Michele N; Meyn, Leslie A et al. (2004) Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191:1124-9

Showing the most recent 10 out of 15 publications